Back
NVIDIA Corp. Vs. Rigel Pharmaceuticals, Inc. Sector Stock Comparison
Sell
49
NVDA
NVIDIA Corp.
Last Price:
$177.59
Seasonality Move:
15.29%
Buy
74
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.99
Seasonality Move:
4.89%
Sell
49
NVIDIA Corp. (NVDA)
is a Sell
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $176.29. The Score for NVDA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NVDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $42.48. The Score for RIGL is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $176.29Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVDA is experiencing slight selling pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $42.48The current trend is moderately bearish and RIGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.23 | Sell |
| Relative Strength Index (14 RSI): | 41.6 | Sell |
| Chaikin Money Flow: | -42106625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (177.84 - 189.2) | Sell |
| Bollinger Bands (100): | (174.55 - 190.17) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 50.38 | Buy |
| Chaikin Money Flow: | 422611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.02 - 48.22) | Sell |
| Bollinger Bands (100): | (27.75 - 42.79) | Buy |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181.54 | Sell |
| 20-day SMA: | 181.25 | Sell |
| 50-day SMA: | 186.62 | Sell |
| 200-day SMA: | 156.33 | Buy |
| 8-day EMA: | 179.93 | Sell |
| 20-day EMA: | 182.26 | Sell |
| 50-day EMA: | 183.5 | Sell |
| 200-day EMA: | 163.94 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.57 | Sell |
| 20-day SMA: | 45.44 | Sell |
| 50-day SMA: | 37.1 | Buy |
| 200-day SMA: | 27.25 | Buy |
| 8-day EMA: | 43.13 | Sell |
| 20-day EMA: | 43.2 | Sell |
| 50-day EMA: | 39.44 | Buy |
| 200-day EMA: | 29.81 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.19 per share, an increase this year of $1.72 per share, and an increase next year of $1.73 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
NVIDIA Corp. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||